Snowden Capital Advisors’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Hold |
15,000
| – | – | 0.01% | 1144 |
|
|
2025
Q1 | $104K | Hold |
15,000
| – | – | ﹤0.01% | 1181 |
|
|
2024
Q4 | $79.6K | Hold |
15,000
| – | – | ﹤0.01% | 1177 |
|
|
2024
Q3 | $54.8K | Hold |
15,000
| – | – | ﹤0.01% | 1203 |
|
|
2024
Q2 | $41K | Hold |
15,000
| – | – | ﹤0.01% | 1176 |
|
|
2024
Q1 | $52.2K | Hold |
15,000
| – | – | ﹤0.01% | 1157 |
|
|
2023
Q4 | $21.5K | Hold |
15,000
| – | – | ﹤0.01% | 1108 |
|
|
2023
Q3 | $21.9K | Hold |
15,000
| – | – | ﹤0.01% | 1048 |
|
|
2023
Q2 | $23.6K | Hold |
15,000
| – | – | ﹤0.01% | 1165 |
|
|
2023
Q1 | $23K | Hold |
15,000
| – | – | ﹤0.01% | 1135 |
|
|
2022
Q4 | $25.2K | Hold |
15,000
| – | – | ﹤0.01% | 1117 |
|
|
2022
Q3 | $18K | Hold |
15,000
| – | – | ﹤0.01% | 1100 |
|
|
2022
Q2 | $25K | Hold |
15,000
| – | – | ﹤0.01% | 1109 |
|
|
2022
Q1 | $36K | Hold |
15,000
| – | – | ﹤0.01% | 1016 |
|
|
2021
Q4 | $56K | Hold |
15,000
| – | – | ﹤0.01% | 1004 |
|
|
2021
Q3 | $94.1K | Hold |
15,000
| – | – | ﹤0.01% | 859 |
|
|
2021
Q2 | $148K | Hold |
15,000
| – | – | 0.01% | 852 |
|
|
2021
Q1 | $140K | Hold |
15,000
| – | – | 0.01% | 780 |
|
|
2020
Q4 | $72K | Hold |
15,000
| – | – | ﹤0.01% | 664 |
|
|
2020
Q3 | $60.2K | Hold |
15,000
| – | – | ﹤0.01% | 568 |
|
|
2020
Q2 | $68.9K | Hold |
15,000
| – | – | 0.01% | 542 |
|
|
2020
Q1 | $48.9K | Hold |
15,000
| – | – | 0.01% | 514 |
|
|
2019
Q4 | $64.7K | Hold |
15,000
| – | – | 0.01% | 575 |
|
|
2019
Q3 | $59K | Hold |
15,000
| – | – | 0.01% | 506 |
|
|
2019
Q2 | $69.8K | Hold |
15,000
| – | – | 0.01% | 501 |
|
|
2019
Q1 | $62.9K | Buy |
15,000
+5,000
| +50% | +$21K | 0.01% | 489 |
|
|
2018
Q4 | $34.3K | Buy |
+10,000
| New | +$34.3K | ﹤0.01% | 462 |
|